Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy

Indexes of left ventricular diastolic filling were measured by radionuclide ventriculography in 28 patients with insulin-dependent diabetes mellitus without evidence of ischemic heart disease. Six patients (21%) had abnormal diastolic filling and differed from diabetic patients with normal filling in their greater severity of cardiac autonomic neuropathy, assessed by noninvasive means, and their lower plasma norepinephrine levels in the supine (131.1 +/- 24.7 versus 356.2 +/- 58.4 pg/ml, p less than 0.01) and upright (224.9 +/- 47.8 versus 673.3 +/- 122.3 pg/ml, p less than 0.005) positions. The diabetic patients determined as having cardiac autonomic neuropathy (n = 15) had depressed left ventricular diastolic filling compared with subjects free of autonomic neuropathy, whether measured as the time to peak filling rate (154.2 +/- 12.0 versus 119.1 +/- 10.6 ms, p less than 0.05) or the time to peak filling rate normalized to the cardiac cycle length (24.3 +/- 2.2 versus 16.2 +/- 1.5%, p less than 0.01). Of the various tests of autonomic nervous system function, the strongest correlate of impaired diastolic filling was orthostasis, measured as the decrease in systolic blood pressure with standing (r = 0.584, p less than 0.001). Thus, in patients with diabetes mellitus, alterations in sympathetic nervous system activity are associated with abnormalities of left ventricular diastolic filling.

This article has been cited by other articles:

				J. W. Sacre, B. Franjic, C. L. Jellis, C. Jenkins, J. S. Coombes, and T. H. Marwick Association of Cardiac Autonomic Neuropathy With Subclinical Myocardial Dysfunction in Type 2 Diabetes J. Am. Coll. Cardiol. Img., December 1, 2010; 3(12): 1207 - 1215. [Abstract] [Full Text] [PDF]

				A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF]

				J. G. Regensteiner, T. A. Bauer, and J. E.B. Reusch Rosiglitazone Improves Exercise Capacity in Individuals With Type 2 Diabetes Diabetes Care, December 1, 2005; 28(12): 2877 - 2883. [Abstract] [Full Text] [PDF]

				R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374. [Abstract] [Full Text] [PDF]

				Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF]

				B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration Diabetes Care, February 1, 2004; 27(2): 448 - 454. [Abstract] [Full Text] [PDF]

				J. C Chatham and A.-M. L Seymour Cardiac carbohydrate metabolism in Zucker diabetic fatty rats Cardiovasc Res, July 1, 2002; 55(1): 104 - 112. [Abstract] [Full Text] [PDF]

				R. R. Russell III, D. Chyun, S. Song, R. S. Sherwin, W. V. Tamborlane, F. A. Lee, M. A. Pfeifer, F. Rife, F. J. T. Wackers, and L. H. Young Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1029 - E1036. [Abstract] [Full Text] [PDF]

				M. J. Stevens, D. M. Raffel, K. C. Allman, F. Dayanikli, E. Ficaro, T. Sandford, D. M. Wieland, M. A. Pfeifer, and M. Schwaiger Cardiac Sympathetic Dysinnervation in Diabetes : Implications for Enhanced Cardiovascular Risk Circulation, September 8, 1998; 98(10): 961 - 968. [Abstract] [Full Text] [PDF]